119-HR-4541 Journalist Public Summary

Public Summary: H.R. 4541 — EARLY Act Reauthorization of 2025

Headline Summary: Reauthorizes a federal breast cancer education program for young women through 2031; cleared committee 48–0 and awaits a House vote. [2]U.S. House of Representatives — Committee Repository — H.R. 4541 AINS — Amendme…

What It Does: H.R. 4541 renews the Young Women’s Breast Health Education and Awareness Requires Learning Young (EARLY) Act, a program in the Public Health Service Act that directs CDC to run evidence‑based campaigns and provider education focused on breast health and early detection for young women. The reauthorization extends current authority from 2026 to 2031. [3]U.S. House Office of the Law Revision Counsel — 42 U.S.C. § 280m — Young women’…

Why It Matters: Advocates argue that younger patients can face delayed detection and unique medical and financial challenges; continuing outreach aims to improve early diagnosis and support. In 2025, breast cancer was projected to cause over 316,000 new diagnoses and about 42,000 deaths, underscoring the need for education and awareness. [4]CDC — Young Breast Cancer Survivors Program (context on needs of young survivor…

• Bipartisan sponsors: Reps. Debbie Wasserman Schultz (D‑FL) with Reps. Mariannette Miller‑Meeks (R‑IA), Kathy Castor (D‑FL), Brian Fitzpatrick (R‑PA), Debbie Dingell (D‑MI), and Diana Harshbarger (R‑TN). [5]Congress.gov — H.R. 4541 — EARLY Act Reauthorization of 2025
• Patient‑advocacy backers include Susan G. Komen, Tigerlily Foundation, Young Survival Coalition, and the Brem Foundation, citing the importance of early detection and tailored education for high‑risk and young women. [6]Office of Rep. Debbie Dingell — Dingell et al. announce introduction of EARLY A…
• Committee action: Reported to the full House, as amended, by a 48–0 roll‑call vote on May 21, 2026, after the Health Subcommittee forwarded it by voice vote on May 13, 2026. [1]U.S. House of Representatives — Committee Repository — H.R. 4541 — Final Passag…

Who’s For It: See above — broad bipartisan support from bill sponsors and unanimous support in full committee; major breast‑cancer advocacy groups publicly back the reauthorization. [1]U.S. House of Representatives — Committee Repository — H.R. 4541 — Final Passag…

• No formal opposition was recorded at markup; the full committee vote was 48–0. [1]U.S. House of Representatives — Committee Repository — H.R. 4541 — Final Passag…

What’s Next: The bill has been ordered reported to the House and awaits scheduling for a floor vote; if it passes the House, it will move to the Senate for consideration. [7]House Committee on Energy & Commerce — E&C Advances 16 Bills to Full House (Pre…